The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Colorectal Cancer Diagnosis and Therapeutics Market Research Report 2024
Synopsis
The global Colorectal Cancer Diagnosis and Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Colorectal Cancer Diagnosis and Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Colorectal Cancer Diagnosis and Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Colorectal Cancer Diagnosis and Therapeutics in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Colorectal Cancer Diagnosis and Therapeutics include Abbott, Beckman Coulter, Clinical Genomics, Volition RX, EDP Biotech, Epigenomics, Novigenix, Siemens and Quest Diagnostics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Diagnosis and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Diagnosis and Therapeutics.
Report Scope
The Colorectal Cancer Diagnosis and Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colorectal Cancer Diagnosis and Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer Diagnosis and Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Beckman Coulter
Clinical Genomics
Volition RX
EDP Biotech
Epigenomics
Novigenix
Siemens
Quest Diagnostics
Metabiomics
Segment by Type
Diagnostics
Therapeutics
Segment by Application
Hospitals
Diagnostic centres
Research institutions
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer Diagnosis and Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Colorectal Cancer Diagnosis and Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Colorectal Cancer Diagnosis and Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Colorectal Cancer Diagnosis and Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Colorectal Cancer Diagnosis and Therapeutics in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Colorectal Cancer Diagnosis and Therapeutics include Abbott, Beckman Coulter, Clinical Genomics, Volition RX, EDP Biotech, Epigenomics, Novigenix, Siemens and Quest Diagnostics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Diagnosis and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Diagnosis and Therapeutics.
Report Scope
The Colorectal Cancer Diagnosis and Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colorectal Cancer Diagnosis and Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer Diagnosis and Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Beckman Coulter
Clinical Genomics
Volition RX
EDP Biotech
Epigenomics
Novigenix
Siemens
Quest Diagnostics
Metabiomics
Segment by Type
Diagnostics
Therapeutics
Segment by Application
Hospitals
Diagnostic centres
Research institutions
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer Diagnosis and Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Diagnostics
1.2.3 Therapeutics
1.3 Market by Application
1.3.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic centres
1.3.4 Research institutions
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Perspective (2019-2030)
2.2 Colorectal Cancer Diagnosis and Therapeutics Growth Trends by Region
2.2.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Colorectal Cancer Diagnosis and Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Colorectal Cancer Diagnosis and Therapeutics Market Dynamics
2.3.1 Colorectal Cancer Diagnosis and Therapeutics Industry Trends
2.3.2 Colorectal Cancer Diagnosis and Therapeutics Market Drivers
2.3.3 Colorectal Cancer Diagnosis and Therapeutics Market Challenges
2.3.4 Colorectal Cancer Diagnosis and Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Diagnosis and Therapeutics Players by Revenue
3.1.1 Global Top Colorectal Cancer Diagnosis and Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Colorectal Cancer Diagnosis and Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Colorectal Cancer Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Diagnosis and Therapeutics Revenue
3.4 Global Colorectal Cancer Diagnosis and Therapeutics Market Concentration Ratio
3.4.1 Global Colorectal Cancer Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Diagnosis and Therapeutics Revenue in 2023
3.5 Colorectal Cancer Diagnosis and Therapeutics Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Diagnosis and Therapeutics Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Diagnosis and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Diagnosis and Therapeutics Breakdown Data by Type
4.1 Global Colorectal Cancer Diagnosis and Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Type (2025-2030)
5 Colorectal Cancer Diagnosis and Therapeutics Breakdown Data by Application
5.1 Global Colorectal Cancer Diagnosis and Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Colorectal Cancer Diagnosis and Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Colorectal Cancer Diagnosis and Therapeutics Market Size (2019-2030)
6.2 North America Colorectal Cancer Diagnosis and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2019-2024)
6.4 North America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size (2019-2030)
7.2 Europe Colorectal Cancer Diagnosis and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2019-2024)
7.4 Europe Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size (2019-2030)
9.2 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Colorectal Cancer Diagnosis and Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Colorectal Cancer Diagnosis and Therapeutics Introduction
11.1.4 Abbott Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Detail
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Colorectal Cancer Diagnosis and Therapeutics Introduction
11.2.4 Beckman Coulter Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2019-2024)
11.2.5 Beckman Coulter Recent Development
11.3 Clinical Genomics
11.3.1 Clinical Genomics Company Detail
11.3.2 Clinical Genomics Business Overview
11.3.3 Clinical Genomics Colorectal Cancer Diagnosis and Therapeutics Introduction
11.3.4 Clinical Genomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2019-2024)
11.3.5 Clinical Genomics Recent Development
11.4 Volition RX
11.4.1 Volition RX Company Detail
11.4.2 Volition RX Business Overview
11.4.3 Volition RX Colorectal Cancer Diagnosis and Therapeutics Introduction
11.4.4 Volition RX Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2019-2024)
11.4.5 Volition RX Recent Development
11.5 EDP Biotech
11.5.1 EDP Biotech Company Detail
11.5.2 EDP Biotech Business Overview
11.5.3 EDP Biotech Colorectal Cancer Diagnosis and Therapeutics Introduction
11.5.4 EDP Biotech Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2019-2024)
11.5.5 EDP Biotech Recent Development
11.6 Epigenomics
11.6.1 Epigenomics Company Detail
11.6.2 Epigenomics Business Overview
11.6.3 Epigenomics Colorectal Cancer Diagnosis and Therapeutics Introduction
11.6.4 Epigenomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2019-2024)
11.6.5 Epigenomics Recent Development
11.7 Novigenix
11.7.1 Novigenix Company Detail
11.7.2 Novigenix Business Overview
11.7.3 Novigenix Colorectal Cancer Diagnosis and Therapeutics Introduction
11.7.4 Novigenix Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2019-2024)
11.7.5 Novigenix Recent Development
11.8 Siemens
11.8.1 Siemens Company Detail
11.8.2 Siemens Business Overview
11.8.3 Siemens Colorectal Cancer Diagnosis and Therapeutics Introduction
11.8.4 Siemens Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2019-2024)
11.8.5 Siemens Recent Development
11.9 Quest Diagnostics
11.9.1 Quest Diagnostics Company Detail
11.9.2 Quest Diagnostics Business Overview
11.9.3 Quest Diagnostics Colorectal Cancer Diagnosis and Therapeutics Introduction
11.9.4 Quest Diagnostics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2019-2024)
11.9.5 Quest Diagnostics Recent Development
11.10 Metabiomics
11.10.1 Metabiomics Company Detail
11.10.2 Metabiomics Business Overview
11.10.3 Metabiomics Colorectal Cancer Diagnosis and Therapeutics Introduction
11.10.4 Metabiomics Revenue in Colorectal Cancer Diagnosis and Therapeutics Business (2019-2024)
11.10.5 Metabiomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
